Brief: PCI Biotech Q4 operating loss narrows to NOK 8.5 million
Feb 9 (Reuters) - PCI Biotech Holding ASA PCIB.OL :
* Q4 pre-tax loss 8.4 million Norwegian crowns ($975,000) versus loss 10.2 million crowns
year ago
* Q4 operating loss 8.5 million crowns versus loss 10.3 million crowns year ago
Source text for Eikon: urn:newsml:reuters.com:*:nHUG1pzhM3
Further company coverage: PCIB.OL
($1 = 8.5928 Norwegian crowns)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))
Recent news on PCI Biotech Holding ASA
See all newsBrief: Euronext Oslo Børs To Delist PCI Biotech Holding Shares
Brief: Euronext Oslo Børs Gets Application From PCI Biotech Holding For Delisting
Brief: PCI Biotech Holding Board Proposes Dissolution, Delisting
Brief: Oslo Bors: PCI Biotech Holding Is Placed In Recovery Box
Brief: PCI Biotech Says Co Initiates Process To Evaluate Opportunity For Structured Wind-Up Process